Concord Biotech Limited (BOM:543960)
India · Delayed Price · Currency is INR 1,638.30
-61.60 (-3.62%)
At close: Aug 6, 2025
Concord Biotech Revenue
Concord Biotech had revenue of 2.18B INR in the quarter ending June 30, 2025, with 0.86% growth. This brings the company's revenue in the last twelve months to 11.92B, up 14.81% year-over-year. In the fiscal year ending March 31, 2025, Concord Biotech had annual revenue of 12.00B with 18.01% growth.
Revenue (ttm)
11.92B
Revenue Growth
+14.81%
P/S Ratio
14.03
Revenue / Employee
8.65M
Employees
1,377
Market Cap
167.18B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 12.00B | 1.83B | 18.01% |
| Mar 31, 2024 | 10.17B | 1.64B | 19.20% |
| Mar 31, 2023 | 8.53B | 1.40B | 19.67% |
| Mar 31, 2022 | 7.13B | 959.91M | 15.56% |
| Mar 31, 2021 | 6.17B | 1.05B | 20.42% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,765.41B |
| HDFC Bank | 2,736.06B |
| Bharti Airtel | 1,839.41B |
| Tata Consultancy Services | 2,561.48B |
| ICICI Bank | 2,054.85B |
| State Bank of India | 3,429.39B |
| Infosys | 1,672.76B |
| Hindustan Unilever | 639.28B |